Allogene Therapeutics, Inc. (ALLO)
NASDAQ·Healthcare·Biotechnology
$1.28
+3.66%
Mkt Cap $459.50M
Analyst Ratings
No recent rating data.
Price Target (12 analysts)
$26.53
Range $3.85 – $55.00
Implied Upside
+1972.7%
Consensus $26.53 vs current $1.28
NASDAQ·Healthcare·Biotechnology
$1.28
+3.66%
Mkt Cap $459.50M
No recent rating data.
Price Target (12 analysts)
$26.53
Range $3.85 – $55.00
+1972.7%
Consensus $26.53 vs current $1.28